Spyre Therapeutics, Inc.SYRENASDAQ
Loading
Revenue Growth TrendStable
Percentile Rank50
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
0.00%
↑ 100% vs avg
Percentile
P50
Within normal range
Streak
1 yr
Consecutive growthStable
Average
-38.63%
Historical baseline
PeriodValue
20250.00%
2024-100.00%
2023-61.96%
2022-87.57%
20210.00%
20200.00%
2019-100.00%
2018-25.30%
201712.47%
2016-23.94%